AR040859A1 - Composiciones farmaceuticas que comprenden una ascomicina - Google Patents
Composiciones farmaceuticas que comprenden una ascomicinaInfo
- Publication number
- AR040859A1 AR040859A1 AR20030102913A ARP030102913A AR040859A1 AR 040859 A1 AR040859 A1 AR 040859A1 AR 20030102913 A AR20030102913 A AR 20030102913A AR P030102913 A ARP030102913 A AR P030102913A AR 040859 A1 AR040859 A1 AR 040859A1
- Authority
- AR
- Argentina
- Prior art keywords
- ascomycin
- pharmaceutical compositions
- weight
- alkyl ester
- component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Composiciones farmacéuticas líquidas o semisólidas de una sola fase sustancialmente exentas de etanol y agua, y que comprenden una ascomicina, tal como pimecrolimus, en un vehículo portador que comprende una mezcla de solventes de tres componentes que suman cuando menos el 40 % en peso/peso del peso total de la composición, y que consiste en: i) un alcanol C3-8 y/o alcanodiol C1-8; ii) un alcohol graso ; y iii) un solvente adicional seleccionado a partir de: a) un alquiléster de ácido alcancarboxílico y/o alquiléster de ácido alcandicarboxílico, y/o b) un co-componente hidrofílico, y/o c) un triglicérido; y opcionalmente, excipientes convencionales adicionales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0218996.7A GB0218996D0 (en) | 2002-08-14 | 2002-08-14 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040859A1 true AR040859A1 (es) | 2005-04-20 |
Family
ID=9942370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030102913A AR040859A1 (es) | 2002-08-14 | 2003-08-12 | Composiciones farmaceuticas que comprenden una ascomicina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20050220850A1 (es) |
| EP (1) | EP1534339B1 (es) |
| JP (1) | JP2005537302A (es) |
| KR (1) | KR100624583B1 (es) |
| CN (1) | CN1674940A (es) |
| AR (1) | AR040859A1 (es) |
| AT (1) | ATE445416T1 (es) |
| AU (1) | AU2003258607B2 (es) |
| BR (1) | BR0313462A (es) |
| CA (1) | CA2495345A1 (es) |
| DE (1) | DE60329687D1 (es) |
| EC (1) | ECSP055597A (es) |
| GB (1) | GB0218996D0 (es) |
| IL (1) | IL166601A0 (es) |
| MX (1) | MXPA05001767A (es) |
| NO (1) | NO20051232L (es) |
| NZ (1) | NZ538138A (es) |
| PE (1) | PE20040330A1 (es) |
| PL (1) | PL373230A1 (es) |
| RU (1) | RU2343919C2 (es) |
| TW (1) | TW200410713A (es) |
| WO (1) | WO2004016289A1 (es) |
| ZA (1) | ZA200500815B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307866D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
| ES2389443T3 (es) * | 2004-04-08 | 2012-10-26 | Meda Pharma S.À.R.L. | Composición de espuma de pimecrolimus que contiene hexilenglicol, opcionalmente alcohol de oleílo, dimetilisosorbida y/o triglicéridos de cadena media |
| US20080207670A1 (en) * | 2004-09-16 | 2008-08-28 | Bayer Healthcare Ag | Dermally Applicable Formulations For Treating Skin Diseases in Animals |
| GB0425255D0 (en) * | 2004-11-16 | 2004-12-15 | Novartis Ag | Pharmaceutical composition |
| DE102005037844A1 (de) * | 2005-08-04 | 2007-04-05 | Intendis Gmbh | Wasserfreies Mehr-Phasen-Gel-System |
| GB0518769D0 (en) * | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
| US9205080B2 (en) | 2006-11-16 | 2015-12-08 | Transderm, Inc. | Methods of treating keratin hyperproliferation disorders using mTOR inhibitors |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| EP2948134B1 (en) | 2013-01-24 | 2020-03-04 | Palvella Therapeutics, Inc. | Compositions for transdermal delivery of mtor inhibitors |
| CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| FR3061009B1 (fr) * | 2016-12-22 | 2020-09-25 | Oreal | Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, au moins un actif hydrophile, et comprenant moins de 7% en poids d’eau |
| FR3061008B1 (fr) * | 2016-12-22 | 2020-05-01 | L'oreal | Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, et comprenant moins de 5% en poids d’eau |
| CN110520097B (zh) * | 2017-01-06 | 2023-10-27 | 帕尔维拉治疗股份有限公司 | Mtor抑制剂的无水组合物及其使用方法 |
| US11000513B2 (en) | 2018-07-02 | 2021-05-11 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
| FR3104962B1 (fr) * | 2019-12-20 | 2021-12-31 | Oreal | Composition cosmétique comprenant au moins une huile polaire, un monoalcool aliphatique, un mélange de polyols et au moins un actif hydrophile |
| CN116602914B (zh) * | 2023-07-05 | 2024-02-13 | 江苏知原药业股份有限公司 | 一种皮炎用乳膏及其生产工艺及其生产设备 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537776A (en) * | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
| DE69125230T2 (de) * | 1990-09-04 | 1997-07-10 | Fujisawa Pharmaceutical Co | Tricyclische Verbindungen enthaltende Salben |
| CH686761A5 (de) * | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
| JPH06345646A (ja) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | ローション剤 |
| CA2183083C (en) * | 1994-03-07 | 2006-01-03 | Charles D. Ebert | Drug-containing adhesive composite transdermal delivery device |
| ES2173978T3 (es) * | 1994-10-26 | 2002-11-01 | Novartis Ag | Utilizacion de un alcohol graso insaturado. |
| GB2327610B (en) * | 1994-11-04 | 1999-06-02 | Novartis Ag | Macrolide compositions |
| HUP0104452A3 (en) * | 1998-04-27 | 2004-05-28 | Fujisawa Pharmaceutical Co | Medicinal compositions, containing tricyclo compounds |
| GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
-
2002
- 2002-08-14 GB GBGB0218996.7A patent/GB0218996D0/en not_active Ceased
-
2003
- 2003-08-12 PE PE2003000805A patent/PE20040330A1/es not_active Application Discontinuation
- 2003-08-12 AR AR20030102913A patent/AR040859A1/es not_active Application Discontinuation
- 2003-08-13 WO PCT/EP2003/008999 patent/WO2004016289A1/en active Application Filing
- 2003-08-13 NZ NZ538138A patent/NZ538138A/en unknown
- 2003-08-13 PL PL03373230A patent/PL373230A1/xx not_active Application Discontinuation
- 2003-08-13 DE DE60329687T patent/DE60329687D1/de not_active Expired - Lifetime
- 2003-08-13 US US10/523,750 patent/US20050220850A1/en not_active Abandoned
- 2003-08-13 EP EP03787785A patent/EP1534339B1/en not_active Expired - Lifetime
- 2003-08-13 CA CA002495345A patent/CA2495345A1/en not_active Abandoned
- 2003-08-13 TW TW092122262A patent/TW200410713A/zh unknown
- 2003-08-13 KR KR1020057002446A patent/KR100624583B1/ko not_active IP Right Cessation
- 2003-08-13 JP JP2004528486A patent/JP2005537302A/ja active Pending
- 2003-08-13 CN CNA03818771XA patent/CN1674940A/zh active Pending
- 2003-08-13 RU RU2005107317/15A patent/RU2343919C2/ru not_active IP Right Cessation
- 2003-08-13 AT AT03787785T patent/ATE445416T1/de not_active IP Right Cessation
- 2003-08-13 BR BR0313462-8A patent/BR0313462A/pt not_active IP Right Cessation
- 2003-08-13 AU AU2003258607A patent/AU2003258607B2/en not_active Ceased
- 2003-08-13 MX MXPA05001767A patent/MXPA05001767A/es unknown
-
2005
- 2005-01-27 ZA ZA200500815A patent/ZA200500815B/xx unknown
- 2005-01-31 IL IL16660105A patent/IL166601A0/xx unknown
- 2005-02-14 EC EC2005005597A patent/ECSP055597A/es unknown
- 2005-03-10 NO NO20051232A patent/NO20051232L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE445416T1 (de) | 2009-10-15 |
| BR0313462A (pt) | 2005-07-05 |
| US20050220850A1 (en) | 2005-10-06 |
| AU2003258607A1 (en) | 2004-03-03 |
| ZA200500815B (en) | 2006-07-26 |
| KR20050042475A (ko) | 2005-05-09 |
| EP1534339A1 (en) | 2005-06-01 |
| ECSP055597A (es) | 2005-04-18 |
| WO2004016289A1 (en) | 2004-02-26 |
| AU2003258607B2 (en) | 2007-01-04 |
| GB0218996D0 (en) | 2002-09-25 |
| EP1534339B1 (en) | 2009-10-14 |
| MXPA05001767A (es) | 2005-04-25 |
| NO20051232L (no) | 2005-05-12 |
| PE20040330A1 (es) | 2004-07-15 |
| KR100624583B1 (ko) | 2006-09-15 |
| TW200410713A (en) | 2004-07-01 |
| IL166601A0 (en) | 2006-01-15 |
| CA2495345A1 (en) | 2004-02-26 |
| JP2005537302A (ja) | 2005-12-08 |
| RU2005107317A (ru) | 2005-10-10 |
| CN1674940A (zh) | 2005-09-28 |
| NZ538138A (en) | 2008-05-30 |
| RU2343919C2 (ru) | 2009-01-20 |
| DE60329687D1 (de) | 2009-11-26 |
| PL373230A1 (en) | 2005-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR040859A1 (es) | Composiciones farmaceuticas que comprenden una ascomicina | |
| CO5700671A2 (es) | Formulaciones topicas que comprenden un derivado de 1-n-arilpirazol y una formamidina | |
| ES2600729T3 (es) | Conjugados de polímeros hiperramificados a través de enlazante escindible no enzimático | |
| RU2011111206A (ru) | Композиции для местного применения, содержащие комбинацию по меньшей мере двух агентов, усиливающих проникновение | |
| PE20030865A1 (es) | Composiciones farmaceuticas para inhibidores de proteasa viral de la hepatitis c | |
| AR023939A1 (es) | COMPUESTOS DERIVADOS DE PIPERIDINA uTILES COMO ANTAGONISTAS DE CCR5, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN, EL USO DE LOS MISMOS SOLOS O EN COMBINACIoN CON OTRO AGENTE ANTIVIRAL PARA LA PREPARACIoN DE UN MEDICAMENTO Y UN KIT | |
| CA2864118A1 (en) | Formulations of bendamustine | |
| IL142535A0 (en) | Pharmaceutical compositions for the treatment of inflammation | |
| EP1914231A3 (de) | 2-Methyl-2-alkenyl-substituierte 1,3-Dioxane als Riechstoffe | |
| AR030312A1 (es) | Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos | |
| ES2173978T3 (es) | Utilizacion de un alcohol graso insaturado. | |
| PE37797A1 (es) | Espesadores asociativos | |
| CO5590905A2 (es) | Composiciones farmaceuticas que comprenden compuestos activos de vitamina d | |
| PE20120032A1 (es) | Composicion farmaceutica oral de un derivado de n-[4-(8-bromo-7-metoxiquinolin-2-il)-1,3-tiazol-2-il]-2-metilpropanamida | |
| UY29825A1 (es) | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones | |
| HRP20110588T1 (hr) | Novi cikloheksenonski spojevi iz antrodia camphorata i njihova primjena | |
| BR0318651A (pt) | processo melhorado para preparar ésteres alquil de ácido graxo usado como biodiesel | |
| CO5700724A2 (es) | Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero | |
| ATE473976T1 (de) | Dipeptidylpeptidase-iv-inhibierende verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten | |
| CO5221123A1 (es) | Desodorante con pequenas particulas de oxido de zinc | |
| BRPI0509854A (pt) | composto, métodos para a preparação regio-especìfica de um 42-éster de rapamicina ou 42-éster de prolina-rapamicina e para a preparação de um 42-éster de prolina-rapamicina, composição, e, produto | |
| AR093297A1 (es) | Formulacion liquida que comprende un compuesto neutralizante de gm-csf | |
| JP2012531470A5 (es) | ||
| AR005827A1 (es) | Compuesto derivado de nucleosidos aciclicos, composicion farmaceutica que lo comprende, uso del mismo en la preparacion de un medicamento y su metodo de preparacion | |
| AR001931A1 (es) | Compuesto de 7-acilamino-3-iminometil (sustituido)cefalosporinas un proceso para su producción intermediarios en su producción una composición farmacéutica que contiene tales compuestos su utilizacióncomo compuestos farmacéuticos y un método para tratar enfermedades microbianas mediante administración de tales compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |